share_log

Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals

Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals

預測未來:14位分析師對Rhythm Pharmaceuticals的預測
Benzinga ·  12/20 20:00
Ratings for Rhythm Pharmaceuticals (NASDAQ:RYTM) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中,14位分析師對Rhythm Pharmaceuticals(納斯達克:RYTM)進行了評級,展現出看好和看淡的不同觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們近期的評級,展示了過去30天內情緒的變化,並與之前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $67.36, a high estimate of $80.00, and a low estimate of $52.00. This upward trend is evident, with the current average reflecting a 6.5% increase from the previous average price target of $63.25.
分析師評估的12個月價格目標提供了進一步的見解,平均目標爲67.36美元,最高估計爲80.00美元,最低估計爲52.00美元。這個上升趨勢很明顯,目前的平均值反映出比之前的平均價格目標63.25美元增加了6.5%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查:一項詳盡的研究
A comprehensive examination of how financial...
對財務專家如...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論